Survival in Operated Early and Local Advanced-Stage (IA-IIIA) Non-Small Cell Lung Cancer
Survival in Operated Early and Local Advanced-Stage (IA-IIIA) Non-Small Cell Lung Cancer
ABSTRACTObjective: The early and local advanced stages (IA-IIIA) of non-small cell lung cancer (NSCLC) warrant the curative treatment approach of surgery. However, despite the surgical approach, survival depends on a number of factors. The aim of the study was to examine the factors that affect survival in operated NSCLC patients with these stages.Methods: A cohort of 231 operated patients with IA, IB, IIA, IIB, and IIIA stages of NSCLC were analyzed. The effects of age, sex, comorbidity, performance status, histopathology of the tumor, T stage, N stage, pleural invasion, surgical resection type and postoperative resection margin invasion on the survival of the patients were examined with Kaplan-Meier and Cox Regression analyses.Results: Advanced age (OR=1.042 for every passing year, CI=1.020-1.064), adenocarcinoma histopathology (OR=1.676 CI=1.178-2.384), N2 invasion (OR=2.389 CI=1.46-4.239), pleural invasion (OR=2.403 CI=1.569-3.678), resection margin invasion (OR=2.401, CI=1.141-5.048) and pneumonectomy as the type of surgical operation (OR=2.313, CI=1.467-3.647) were found to be independent prognostic factors of mortality.Conclusion: Follow-up of the NSCLC cases with advanced age, an adenocarcinoma type, visceral pleural invasion, N2-lymph node invasion, a history of pneumonectomy, and a resection margin invasion should be undertaken more attentively during planning of surgical operation and postoperative period. J Clin Exp Invest 2016; 7 (2): 125-133Key words: Survival, mortality, performance score, operated, non-small cell lung cancer
___
- 1. Scott WJ, Howington J, Feigenberg S, et al. Treatment of
non-small cell lung cancer stage I and stage II: ACCP
evidence-based clinical practice guidelines (2
nd
edition).
Chest. 2007;132:234s-42s.
2. Birim O, Zuydendorp HM, Maat AP, et al. Lung resection
for non-small-cell lung cancer in patients older than 70:
mortality, morbidity, and late survival compared with the
general population. Ann Thorac Surg. 2003;76:1796-801.
3. Thorsteinsson H, Alexandersson A, Oskarsdottir GN, et al.
Resection rate and outcome of pulmonary resections for
non-small-cell lung cancer: a nationwide study from Ice
-
land. J Thorac Oncol. 2012;7:1164-9.
4. Oskarsdottir GN, Skuladottir R, Isaksson HJ, et al. [Factors
predictive of survival after lobectomy for non-small cell
lung cancer in Iceland during 1999-2008]. Laeknabladid.
2010;96:251-7.
5. Yu DP, Bai LQ, Xu SF, et al. [Impact of TNM staging and
treatment mode on the prognosis of non-small cell lung
cancer]. Zhonghua zhong liu za zhi [Chinese J Oncol].
2009;31:465-8.
6. Oken MM, Creech RH, Tormey DC, et al. Toxicity and re
-
sponse criteria of the Eastern Cooperative Oncology Group.
Am J Clin Oncol. 1982;5:649-6.
7. Goldstraw P. The 7
th
Edition of TNM in Lung Cancer: what
now? J Thoracic Surg Oncol. 2009;4:671-3.
8. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statis
-
tics, 2000. CA Cancer J Clin. 2000;50:7-33.
9. Liu M, Cai X, Yu W, et al. Clinical significance of age at
diagnosis among young non-small cell lung cancer patients
under 40 years old: a population-based study. Oncotarget.
2015;6:44963-70
10. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in
women: age, smoking, histology, performance status, stage,
initial treatment and survival. Population-based study of 20
561 cases. Ann Oncol. 2002;13:1087-93.
11. Radzikowska E, Głaz P, Roszkowski K. Lung cancer in
women: age, smoking, histology, performance status, stage,
initial treatment and survival. Population-based study of 20
561 cases. Ann Oncol. 2002;13:1087-93.
12. Visbal AL, Williams BA, Nichols FC, et al. Gender differ
-
ences in non–small-cell lung cancer survival: an analysis
of 4,618 patients diagnosed between 1997 and 2002. Ann
Thorac Surg. 2004;78:209-15.
13. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live
longer following lung resection for carcinoma? Eur J Car
-
diothorac Surg. 2002;21:319-25.
14. Kawaguchi T, Takada M, Kubo A, et al. Performance status
and smoking status are independent favorable prognostic
factors for survival in non-small cell lung cancer: a compre
-
hensive analysis of 26,957 patients with NSCLC. J Thorac
Oncol. 2010;5:620-30.
15. Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor
size and survival in patients with stage IA non-small cell
lung cancer. Chest. 2000;117:1568-71.
16. Harpole DH, Herndon JE, Young WG, et al. Stage I nons
-
mall cell lung cancer. A multivariate analysis of treatment
methods and patterns of recurrence. Cancer. 1995;76:787-
96.
17. Ma Q, Liu D, Guo Y, et al. Surgical therapeutic strategy
for non-small cell lung cancer with mediastinal lymph node
metastasis (N2). Zhongguo Fei Ai Za Zhi. 2010;13:342-8.
18. Dai Y, Su XD, Long H, et al. Survival analysis of 220 pa
-
tients with completely resected stage-II non-small cell lung
cancer. Chinese J Cancer. 2010;29:538-44.
19. Lakha S, Gomez JE, Flores RM, Wisnivesky JP. Prognostic
significance of visceral pleural involvement in early-stage
lung cancer. Chest. 2014;146:1619-26.
20. Kang JH, Kim KD, Chung KY. Prognostic value of visceral
pleura invasion in non-small cell lung cancer. Eur J Cardio
-
thorac Surg. 2003;23:865-9.
21. Naito Y, Goto K, Nagai K, et al. Vascular invasion is a strong
prognostic factor after complete resection of node-negative
non-small cell lung cancer. Chest. 2010;138:1411-7.
22. Ruffini E, Asioli S, Filosso PL, et al. Significance of the
presence of microscopic vascular invasion after complete
resection of Stage I-II pT1-T2N0 non-small cell lung can
-
cer and its relation with T-Size categories: did the 2009 7th
edition of the TNM staging system miss something? J Tho
-
rac Oncol. 2011;6:319-26.
23. Chandrachud L, Pendleton N, Chisholm D, et al. Relation
-
ship between vascularity, age and survival in non-small-cell
lung cancer. Brit J Cancer. 1997;76:1367-70.
24. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and
survival after resection for bronchogenic carcinoma based
on the 1997 TNM-staging classification: the Japanese expe
-
rience. Ann Thorac Surg. 2001;71:1759-64.
25. Kates M, Swanson S, Wisnivesky JP. Survival following
lobectomy and limited resection for the treatment of stage
I non-small cell lung cancer<=1 cm in size: a review of
SEER data. Chest. 2011;139:491-6.
26. Kim DJ, Lee JG, Lee CY, et al. Long-term survival follow
-
ing pneumonectomy for non-small cell lung cancer: clinical
implications for follow-up care. Chest. 2007;132:178-84.
27. Martini N, Bains MS, Burt ME, et al. Incidence of local
recurrence and second primary tumors in resected stage I
lung cancer. J Thorac Cardiovasc Surg. 1995;109:120-9.
28. Drukin E, Preis VG, Mikhnin AE, et al. [Analysis of
one-year mortality of radically operated patients over 70
years with nonsmall cell lung cancer]. Voprosy Onkologii.
2014;60:88-93.
29. Ng CS, Lee TW, Wan S, et al. Thoracotomy is associated
with significantly more profound suppression in lympho
-
cytes and natural killer cells than video-assisted thoracic
surgery following major lung resections for cancer. J Invest
Surg. 2005;18:81-8.
30. Poullis M, McShane J, Shaw M, et al. Bronchial resection
margin and long-term survival in non-small-cell lung can
-
cer. Asian Cardiovasc Thorac Ann. 2012;20:432-8.
31. Yue D, Wang C. [Surgical resection standard and prognostic
analysis of non-small cell lung cancer]. Zhonghua Zhong
Liu Za Zhi. 2014;36:532-5.